Stem Cells Market Size To Hit USD 48.83 Bn By 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Stem Cells Market

5.1. COVID-19 Landscape: Stem Cells Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Stem Cells Market, By Product

8.1. Stem Cells Market Revenue and Volume Forecast, by Product

8.1.1. Adult Stem Cells

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Very Small Embryonic Like Stem Cells

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Human Embryonic Stem Cells

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Induced Pluripotent Stem Cells

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Stem Cells Market, By Application

9.1. Stem Cells Market Revenue and Volume Forecast, by Application

9.1.1. Regenerative Medicine

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. v

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Stem Cells Market, By Technology

10.1. Stem Cells Market Revenue and Volume Forecast, by Technology

10.1.1. Cell Acquisition

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Cryopreservation

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Cell production

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Expansion and Sub-Culture

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Stem Cells Market, By Therapy

11.1. Stem Cells Market Revenue and Volume Forecast, by Therapy

11.1.1. Allogenic

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Autologous

11.1.2.1. Market Revenue and Volume Forecast

Chapter 12. Global Stem Cells Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product

12.1.2. Market Revenue and Volume Forecast, by Application

12.1.3. Market Revenue and Volume Forecast, by Technology

12.1.4. Market Revenue and Volume Forecast, by Therapy

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product

12.1.5.2. Market Revenue and Volume Forecast, by Application

12.1.5.3. Market Revenue and Volume Forecast, by Technology

12.1.5.4. Market Revenue and Volume Forecast, by Therapy

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product

12.1.6.2. Market Revenue and Volume Forecast, by Application

12.1.6.3. Market Revenue and Volume Forecast, by Technology

12.1.6.4. Market Revenue and Volume Forecast, by Therapy

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product

12.2.2. Market Revenue and Volume Forecast, by Application

12.2.3. Market Revenue and Volume Forecast, by Technology

12.2.4. Market Revenue and Volume Forecast, by Therapy

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product

12.2.5.2. Market Revenue and Volume Forecast, by Application

12.2.5.3. Market Revenue and Volume Forecast, by Technology

12.2.5.4. Market Revenue and Volume Forecast, by Therapy

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product

12.2.6.2. Market Revenue and Volume Forecast, by Application

12.2.6.3. Market Revenue and Volume Forecast, by Technology

12.2.6.4. Market Revenue and Volume Forecast, by Therapy

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product

12.2.7.2. Market Revenue and Volume Forecast, by Application

12.2.7.3. Market Revenue and Volume Forecast, by Technology

12.2.7.4. Market Revenue and Volume Forecast, by Therapy

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product

12.2.8.2. Market Revenue and Volume Forecast, by Application

12.2.8.3. Market Revenue and Volume Forecast, by Technology

12.2.8.4. Market Revenue and Volume Forecast, by Therapy

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product

12.3.2. Market Revenue and Volume Forecast, by Application

12.3.3. Market Revenue and Volume Forecast, by Technology

12.3.4. Market Revenue and Volume Forecast, by Therapy

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product

12.3.5.2. Market Revenue and Volume Forecast, by Application

12.3.5.3. Market Revenue and Volume Forecast, by Technology

12.3.5.4. Market Revenue and Volume Forecast, by Therapy

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product

12.3.6.2. Market Revenue and Volume Forecast, by Application

12.3.6.3. Market Revenue and Volume Forecast, by Technology

12.3.6.4. Market Revenue and Volume Forecast, by Therapy

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product

12.3.7.2. Market Revenue and Volume Forecast, by Application

12.3.7.3. Market Revenue and Volume Forecast, by Technology

12.3.7.4. Market Revenue and Volume Forecast, by Therapy

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product

12.3.8.2. Market Revenue and Volume Forecast, by Application

12.3.8.3. Market Revenue and Volume Forecast, by Technology

12.3.8.4. Market Revenue and Volume Forecast, by Therapy

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product

12.4.2. Market Revenue and Volume Forecast, by Application

12.4.3. Market Revenue and Volume Forecast, by Technology

12.4.4. Market Revenue and Volume Forecast, by Therapy

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product

12.4.5.2. Market Revenue and Volume Forecast, by Application

12.4.5.3. Market Revenue and Volume Forecast, by Technology

12.4.5.4. Market Revenue and Volume Forecast, by Therapy

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product

12.4.6.2. Market Revenue and Volume Forecast, by Application

12.4.6.3. Market Revenue and Volume Forecast, by Technology

12.4.6.4. Market Revenue and Volume Forecast, by Therapy

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product

12.4.7.2. Market Revenue and Volume Forecast, by Application

12.4.7.3. Market Revenue and Volume Forecast, by Technology

12.4.7.4. Market Revenue and Volume Forecast, by Therapy

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product

12.4.8.2. Market Revenue and Volume Forecast, by Application

12.4.8.3. Market Revenue and Volume Forecast, by Technology

12.4.8.4. Market Revenue and Volume Forecast, by Therapy

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product

12.5.2. Market Revenue and Volume Forecast, by Application

12.5.3. Market Revenue and Volume Forecast, by Technology

12.5.4. Market Revenue and Volume Forecast, by Therapy

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product

12.5.5.2. Market Revenue and Volume Forecast, by Application

12.5.5.3. Market Revenue and Volume Forecast, by Technology

12.5.5.4. Market Revenue and Volume Forecast, by Therapy

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product

12.5.6.2. Market Revenue and Volume Forecast, by Application

12.5.6.3. Market Revenue and Volume Forecast, by Technology

12.5.6.4. Market Revenue and Volume Forecast, by Therapy

Chapter 13. Company Profiles

13.1. STEMCELL Technologies, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Osiris Therapeutics, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Cynata Therapeutics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Human Longevity, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Advanced Cell Technology, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. BIOTIME, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Mesoblast Limited

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Promethera Biosciences S.A. / N.V.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Merck Group

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Takara Bio Group

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The stem cells market was reached at USD 18.65 billion in 2025 and is anticipated to reach around USD 48.83 billion by 2034.

The global stem cells market is expected to exhibit a CAGR of 11.30% during the forecast period 2025 and 2034.

Since past few years, stem cells market is growing with the increasing investment in stem cell-based research by biopharmaceutical and pharmaceutical firm along with the success of regenerative medicines. Stem cells market is growth is backed by escalating number of clinical trials across the world. Some of the major factors driving the growth of the stem cells market include advancement in stem cell manufacturing technology as well as increasing harvest awareness regarding therapeutic potency. High occurrences of infections have steered the development of vaccines using various human diploid and non-tumorigenic cell lines.

The adult stem cells dominated the global market in 2024 and is expected to hold the dominance over the forecast period.

North America held the largest share in the market and is anticipated to continue its dominance over the forecast period due to existence of organized and developed healthcare systems which uplift research and development in the U.S. and Canada.

Asia Pacific is likely to grow with the highest Compound Annual Growth Rate (CAGR) owing to wide usage of stem cells in regenerative medicines particularly in the sector of dermatology.

Stem Cells market is highly competitive and includes several major players such as STEMCELL Technologies, Inc., Osiris therapeutics, Inc., Cynata Therapeutics, Human Longevity, Inc., Advanced Cell Technology, Inc., BIOTIME, Inc.Mesoblast Limited, Promethera Biosciences S.A. N.V., Merck Group, Takara Bio Group.

In terms of application segments the oncology segments exhibited the highest growth rate owing to the existence of various pipeline products for the treatment of cancer and tumors.